⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Official Title: A LARGE-SCALE TRIAL EVALUATING ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION OF NON-SMALL CELL LUNG CANCER

Study ID: NCT00002823

Conditions

Lung Cancer

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.

Detailed Description: OBJECTIVES: I. Compare the impact on overall survival of adjuvant cisplatin and either a vinca alkaloid or etoposide (with or without radiotherapy) vs. no adjuvant chemotherapy in patients with completely resected stage I/II/III non-small cell lung cancer. II. Assess the frequency of treatment-related deaths and severe toxic effects. III. Describe the patterns of failure, second malignancies, and toxic effects associated with each treatment regimen. OUTLINE: This is a randomized, multicenter study. Patients are stratified by participating institution, type of prior surgery, and pathologic stage. Each participating center will determine which combination chemotherapy regimen and which of three cisplatin doses will be given to all patients treated at that center. The treatment group receives cisplatin combined with either vindesine, vinblastine, vinorelbine, or etoposide every 3-4 weeks for 3-4 courses, depending on the dose of cisplatin. The second group receives no adjuvant chemotherapy. Treating institutions determine prior to entering the trial which patients receive adjuvant radiotherapy: none; those with node-positive disease; those with N1 disease only; those with N2 disease only; or those eligible for a randomized radiotherapy trial. For patients in the treatment group, radiotherapy begins 3-4 weeks after the last course. Patients are followed at 6 months, then annually. PROJECTED ACCRUAL: A maximum of 3,300 patients will be accrued for this study.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Comprehensive Cancer Center at JFK Medical Center, Atlantis, Florida, United States

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

Getlac, Buenos Aires, , Argentina

South Eastern Sydney Area Health Service, Randwick, New South Wales, Australia

Royal Adelaide Hospital, Adelaide, South Australia, Australia

Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia

Western Hospital, Melbourne, Victoria, Australia

Alfred Hospital, Melbourne, Victoria, Australia

Royal Melbourne Hospital, Parkville, Victoria, Australia

AKH Vienna, Vienna, , Austria

A.Z. St. Jan, Brugge, , Belgium

Universitair Ziekenhuis Antwerpen, Edegem, , Belgium

U.Z. Gasthuisberg, Leuven, , Belgium

AZ Zusters Van Barmhartigheid, Ronse, , Belgium

Sint Elizabeth Ziekenhuis, Zottegem, , Belgium

Porto Alegre Hospital, Porto Alegre, Rio Grande do Sul, Brazil

Instituto Nacional de Cancer, Rio de Janeiro, , Brazil

University of Clementino Fraga, Rio De Janeiro, , Brazil

Hospital A.C. Camargo, Sao Paulo, , Brazil

Clinica Las Nieves, Santiago, , Chile

Hospital Militar Central, Bogota, , Colombia

Instituto Nacional De Cancerologia, Bogota, , Colombia

Chest Disease Clinic, Charles University, Prague (Praha), , Czech Republic

National Cancer Institute of Egypt, Cairo, , Egypt

Institute for Lung Diseases, Belgrade, , Former Yugoslavia

Centre Hospitalier Regional et Universitaire d'Angers, Angers, , France

Centre Paul Papin, Angers, , France

C.H. Armentieres, Armentieres, , France

Centre Hospital General Robert Ballanger, Aulnay Sous Bois, , France

C.H. Henri Mondor, Aurillac, , France

Clinique Hauts De Seine Bagneux, Bagneux, , France

C.H.G. Beauvais, Beauvais, , France

Hopital Avicenne, Bobigny, , France

C.M.C. Du Cedre, Bois Guillaume (Rouen), , France

Institut Bergonie, Bordeaux, , France

CHU de Caen, Caen, , France

Centre Regional Francois Baclesse, Caen, , France

Centre Du Meridien, Cannes, , France

Hopital Fontenoy, Chartres, , France

Hopital Antoine Beclere, Clamart, , France

Centre Hospitalier General, Compiegne, , France

Hopital Intercommunal De Creteil, Creteil, , France

Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, , France

Hopital D'Etampes, Etampes, , France

C.H. De Grasse, Grasse, , France

Centre Hospitalier de Lagny, Lagny, , France

C.H.G. Du Havre-Hopital J. Monod, Le Havre, , France

Centre Oscar Lambret, Lille, , France

Centre Leon Berard, Lyon, , France

Assistance Publique Hopitaux de Marseille Hopitaux Sud, Marseille, , France

C.H. Nord Mayenne, Mayenne, , France

Hopital Clinique Claude Bernard, Metz, , France

Centre de Radiologie et de Traitement des Tumeurs, Meudon-La-Foret, , France

Hopital Arnaud de Villeneuve, Montpellier, , France

Clinique Hartmann, Neuilly sur Seine, , France

Centre Antoine Lacassagne, Nice, , France

Institut Mutualiste Montsouris, Paris, , France

Hospital Saint-Joseph, Paris, , France

Institut Curie - Section Medicale, Paris, , France

Hopital Tenon, Paris, , France

C.H.G. De Pau, Pau, , France

Hopital Jean Bernard, Poitiers, , France

CHU De Pontchaillou, Rennes, , France

Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, , France

Centre du Rouget, Sarcelles, , France

C.H. De Sens, Sens, , France

Hopitaux Universitaire de Strasbourg, Strasbourg, , France

C.H.G. Troyes, Troyes, , France

Centre Alexis Vautrin, Vandoeuvre-les-Nancy, , France

Institut Gustave Roussy, Villejuif, , France

University Hospital of Heraklion, Iraklion (Heraklion), Crete, Greece

Evangelismos Hospital, Athens, , Greece

Athens University-Laikon General Hospital, Athens, , Greece

Sismanoglio Hospital, Athens, , Greece

Sotiria Hospital Chest Diseases, Athens, , Greece

Metaxa's Memorial Cancer Hospital, Piraeus, , Greece

University of Patras Medical School, Rio Patras, , Greece

George Papanicolaou General Hospital, Thessaloniki, , Greece

Kaplan Hospital, Rehovot, , Israel

Tel-Aviv Medical Center, Tel-Aviv, , Israel

Istituto Europeo Di Oncologia, Milano, , Italy

Federico II University Medical School, Naples, , Italy

Ospedale Cervello, Palermo, , Italy

Ospedale Oncologico M. Ascoli, Palermo, , Italy

Ospedale Civile Rimini, Rimini, , Italy

Ospedale San Filippo Neri, Rome, , Italy

Clinica Ars Medica, Rome, , Italy

Istituto Di Clinica Chirurgica, Torino, , Italy

Ospedale Molinette, Turin, , Italy

Universita Degli Studi di Udine, Udine, , Italy

Ospedale Di Borgo Trento, Verona, , Italy

National Kinki Central Hospital, Osaka, , Japan

Lithuanian Oncology Center, Vilnius, , Lithuania

Institute of Radiotherapy and Oncology, Skopje, , Macedonia, The Former Yugoslav Republic of

Institut National D'Oncologie, Rabat, , Morocco

University of Tromso, Tromso, , Norway

Lung Centre of the Philippines, Quezon City Diliman, , Philippines

Bialystok Medical School, Bialystok, , Poland

Institute of Oncology, Lodz, , Poland

Department of Children Hematology/Oncology University of Medicine Wroclaw, Wroclaw, , Poland

K. Dluski Hospital-Medical Academy, Wroclaw, , Poland

Regional Hospital for Lung Disease, Zdunowo, , Poland

Hospital Santa Maria, Lisbon (Lisboa), , Portugal

University of Ljubljana, Ljubljana, , Slovenia

Groote Schuur Hospital, Cape Town, Cape Town, , South Africa

Sandton Oncology Centre, Johannesburg, , South Africa

Park Lane Oncology Practice, Johannesburg, , South Africa

Institut Catala d'Oncologia - Hospital Duran i Reynals, Barcelona, , Spain

Hospital Virgen de las Nieves, Granada, , Spain

Hospital Arnau Vilanova, Valencia, , Spain

Sahlgrenska University Hospital, Gothenburg (Goteborg), , Sweden

University Hospital of Linkoping, Linkoping, , Sweden

Lund University Hospital, Lund, , Sweden

Karolinska Hospital, Stockholm, , Sweden

University Hospital - Uppsala, Uppsala, , Sweden

University Hospital, Basel, , Switzerland

Ospedale San Giovanni, Bellinzona, , Switzerland

Ratisches Kantons und Regionalspital, Chur, , Switzerland

Hopital Cantonal Universitaire de Geneva, Geneva, , Switzerland

Kantonsspital, Luzern, Luzern (Lucerne), , Switzerland

City Hospital Triemli, Zurich, , Switzerland

Universitaetsspital, Zurich, , Switzerland

Hopital Universitaire F. Bourguiba, Monastir, , Tunisia

Contact Details

Name: Thierry L. Le Chevalier, MD

Affiliation: Gustave Roussy, Cancer Campus, Grand Paris

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: